Table 5.
Binding Affinities (Kcal/mol) from 1-Click Docking between conventional Ligands and Oil Blend Compounds Targeting VEGF
| Ligand | Target Molecule |
Molecular Affinity (Kcal/mol) |
|---|---|---|
| Cisplatin | CEA | -6.1 |
| Paclitaxel | CEA | -6.7 |
| Bevacizumab | CEA | -6.4 |
| Pembrolizumab | CEA | -6.6 |
| Topotecan | CEA | -5.9 |
| Curcumin | CEA | -7.7 |
| Resveratrol | CEA | -8.1 |
| Epigallocatechin gallate | CEA | -7.9 |
| Olaparib | CEA | -7.8 |
| Everolimus | CEA | -7.7 |
| Temsirolimus | CEA | -6.9 |
| Oleic Acid | CEA | -5.4 |
| g-Tocopherol | CEA | -4.9 |
| Sitosterol | CEA | -5.5 |
| quercetin 3-O-glucoside | CEA | -8.9 |
| apigenin 5-O-glucoside | CEA | -9.4 |
| kaempferol 3-O-glycoside | CEA | -7.9 |
| Eugenol | CEA | -8.8 |
| Eugenyl Acetate | CEA | -7.9 |
| b-Caryophillene | CEA | -6.7 |